Tag - Focal segmental glomerulosclerosis

From implementing global kidney health commitments to results of the Phase 2 ACTION2 trial: Read the latest ISN Journal summaries  

Kidney International®   Implementing the commitments of the WHO Kidney Health Resolution: Initial steps in three diverse settings  Chronic kidney disease (CKD) affects 850 million people globally, with the highest burden in low- and middle-income countries. The WHA78 kidney health resolution offers a unique opportunity to advance prevention and care.   This editorial presents case studies from Guatemala, Thailand,...

Sparsentan Decreased Proteinuria, but Failed to Slow eGFR Decline in FSGS: Data From the DUPLEX Trial – New Selection of Global Trials Out Now!

ISN-ACT Global Trials Focus Subgroup member Anastasiia Zykova summarizes the design and outcomes of the team's latest "Trial of the Month." Stay updated on the latest research and developments in kidney care: Access the new selection of global trials from the ISN-ACT initiative here. The "Trial of the Month" is available in several languages. Sparsentan Versus Irbesartan...